Asthma clinical trials in Pennsylvania
12 studies for Asthma are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)
- GSK Investigational Site, DuBois
- GSK Investigational Site, Philadelphia
RecruitingPhase 3
Ages 12 to 80 · All sexes · Updated Nov 12, 2026 · NCT07782996Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Pittsburgh
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Nov 10, 2026 · NCT06307665A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Clinical Research Associates of Central PA, LLC, DuBois
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Nov 6, 2026 · NCT06977581A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- University of Pittsburgh Medical Center, Pittsburgh
- Allergy and Clinical Immunology Associates, Pittsburgh
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Nov 5, 2026 · NCT07219173A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe Asthma
- Allergy and Clinical Immunology Associates, Pittsburgh
RecruitingPhase 3
Ages 12 to 80 · All sexes · Updated Nov 5, 2026 · NCT07869043Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Research Site, Philadelphia
- Research Site, Smithfield
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 30, 2026 · NCT06932263Acoustic Waveform Respiratory Evaluation
- University of Pittsburgh, Pittsburgh
RecruitingHealthy volunteers welcome
Ages 8 to 70 · All sexes · Updated Oct 5, 2026 · NCT06512064A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
- GSK Investigational Site, DuBois
- GSK Investigational Site, Wyomissing
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Aug 17, 2026 · NCT07456033Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
- The University of Pittsburgh Asthma Institute at UPMC, Pittsburgh
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT04743791A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
- Research site, Pittsburgh
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 28, 2026 · NCT07532265A Study of CDX-622 in Participants With Mild to Moderate Asthma
- University of Pittsburgh Asthma and Environmental Lung Health Institute at UPMC, Pittsburgh
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT07330778Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
- GSK Investigational Site, DuBois
- GSK Investigational Site, Philadelphia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT06979323From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.